Search Results - "Slebos, RJ"

Multiple hyperplastic polyps in the stomach: Evidence for clonality and neoplastic potential by Dijkhuizen, SM, Entius, MM, Clement, MJ, Polak, MM, Van den Berg, FM, Craanen, ME, Slebos, RJ, Offerhaus, GJ

“…The origin and neoplastic potential of gastric epithelial polyps remains an area of great interest, and treatment choices are a topic of controversy. This…”
Get full text

Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage by SLICHENMYER, W. J, NELSON, W. G, SLEBOS, R. J, KASTAN, M. B

“…Cell cycle checkpoints regulate progression through the cell cycle. In yeast, loss of the G2 checkpoint by mutation of the rad9 gene results in increased…”
Get full text

Human Papillomavirus 16 E6 Expression Disrupts the p53-Mediated Cellular Response to DNA Damage by Kessis, Theodore D., Slebos, Robert J., Nelson, William G., Kastan, Michael B., Plunkett, Beverly S., Han, Sung M., Lorincz, Attila T., Hedrick, Lora, Cho, Kathleen R.

“…Infection with certain types of human papillomaviruses (HPV) is highly associated with carcinomas of the human uterine cervix. However, HPV infection alone…”
Get full text

K-ras Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung by Slebos, Robert J.C, Kibbelaar, Robert E, Dalesio, Otilia, Kooistra, Anko, Stam, Jacob, Meijer, Chris J.L.M, Wagenaar, Sjoerd S, Vanderschueren, Ronald G.J.R.A, van Zandwijk, Nico, Mooi, Wolter J, Bos, Johannes L, Rodenhuis, Sjoerd

“…THE concept of oncogenes has revolutionized our understanding of cancer, but there have been disappointingly few situations in which the detection of activated…”
Get full text

p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix by Kessis, TD, Slebos, RJ, Han, SM, Shah, K, Bosch, XF, Munoz, N, Hedrick, L, Cho, KR

“…The p53 gene is the most frequently altered gene known thus far in a wide variety of human cancers. Inactivation of p53, either through mutation or through…”
Get full text

Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients by Hruban, RH, Sturm, PD, Slebos, RJ, Wilentz, RE, Musler, AR, Yeo, CJ, Sohn, TA, van Velthuysen, ML, Offerhaus, GJ

“…It can be difficult to distinguish benign bile duct proliferations (BDPs) from well-differentiated metastatic peripancreatic adenocarcinomas on histological…”
Get full text

The molecular genetics of human lung cancer by Slebos, R J, Rodenhuis, S

“…With the development of molecular biological techniques the search for genetic alterations in cancer cells has resulted in the beginning of a molecular…”
Get more information